Home › Alcohol Use Disorder (AUD) › Colorado › Aurora
Alcohol Use Disorder (AUD) clinical trials in Aurora, CO
5 studies for Alcohol Use Disorder (AUD) are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Cannabidiol and Alcohol Use Disorder Phenotypes
RecruitingPhase 2
- University of Colorado School of Medicine- Anschutz Medical Campus, Aurora
Alcohol Use Disorder and Cannabidiol
RecruitingPhase 2/3
- University of Colorado Anschutz, Aurora
Human Laboratory Study of Apremilast for Alcohol Use Disorder
RecruitingPhase 2
- University of Colorado, Aurora
Brexpiprazole in Alcohol Use Disorder
RecruitingPhase 2
- University of Colorado Anschutz Medical Campus, Aurora
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
RecruitingObservational study
- University of Colorado Hospital, Aurora
About Alcohol Use Disorder (AUD)
An alcohol use disorder (AUD) is drinking that causes distress and harm. AUD can range from mild to severe (alcoholism). Learn the signs that you may have a problem with drinking.
More about Alcohol Use Disorder (AUD) on MedlinePlus
Alcohol Use Disorder (AUD) trials in other cities
- New Haven, CT17 studies
- Washington, DC14 studies
- Baltimore, MD11 studies
- Providence, RI8 studies
- Los Angeles, CA7 studies
- Philadelphia, PA7 studies
- Portland, OR5 studies
- Chicago, IL5 studies
- San Diego, CA5 studies
- New York City, NY5 studies
- Seattle, WA5 studies
- Boston, MA5 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer27 studies
- Metastatic Cancer25 studies
- Ovarian Cancer25 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Prostate Cancer19 studies
- Heart Failure18 studies
- Melanoma18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.